SCHEMBL4908736

SCHEMBL4908736

Cc1ccc(S(=O)(=O)NCCc2ccc(-c3ccc(C(C)C)cc3)cc2)cc1C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.59
TP53 P04637 4/20 0.56
MAPT P10636 3/20 0.56
F10 P00742 1/20 0.53
PRSS1 P07477 1/20 0.53
PRSS2 P07478 1/20 0.53
PRSS3 P35030 1/20 0.53
RAB9A P51151 1/20 0.50
AKR1C3 P42330 3/20 0.49
RECQL P46063 1/20 0.48
MAPK1 P28482 2/20 0.47
PKM P14618 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
SFRP1 Q8N474 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4909023 0.90 LMNA (0.53) LMNATP53MAPTF10PRSS1
SCHEMBL4902838 0.89 AKR1C3 (0.60) LMNATP53MAPTAKR1C3RECQL
SCHEMBL4909082 0.89 AKR1C3 (0.62) LMNATP53MAPTAKR1C3RECQL
SCHEMBL4906406 0.88 LMNA (0.57) LMNATP53MAPTAKR1C3RECQL
SCHEMBL4904104 0.88 LMNA (0.57) LMNATP53MAPTAKR1C3RECQL
SCHEMBL4901112 0.87 LMNA (0.54) LMNATP53MAPTAKR1C3RECQL
SCHEMBL4905692 0.87 LMNA (0.56) LMNATP53MAPTAKR1C3RECQL
SCHEMBL4897963 0.86 LMNA (0.53) LMNATP53MAPTF10PRSS1
SCHEMBL4901071 0.85 MAPT (0.58) LMNATP53MAPTAKR1C3RECQL
SCHEMBL4898223 0.85 AKR1C3 (0.63) LMNAMAPTAKR1C3HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885TP53 3260/4885MAPT 1858/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885TP53 3421/4885MAPT 1786/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885TP53 3421/4885MAPT 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.